22157.jpg
2021 Insights on the Drug Delivery in Central Nervous System Diseases Global Market - 76 Companies Profiled with 101 Collaborations
April 30, 2021 04:28 ET | Research and Markets
Dublin, April 30, 2021 (GLOBE NEWSWIRE) -- The "Drug Delivery in Central Nervous System Diseases - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to...
22157.jpg
Non-Viral Drug Delivery Systems Market, 2030
April 28, 2021 07:03 ET | Research and Markets
Dublin, April 28, 2021 (GLOBE NEWSWIRE) -- The "Non-Viral Drug Delivery Systems (Focus on Intracellular Technologies and Intracellular Biologics) Market by Type of Molecule and Key Geographies:...
fior-markets-logo.jpg
Global Drug Delivery Technology Market Is Expected to Reach USD 9000.89 billion by 2028 : Fior Markets
February 11, 2021 01:00 ET | Fior Markets
Newark, NJ, Feb. 11, 2021 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global drug delivery technology market is expected to grow from USD 4827.03 billion in 2020 and to...
22157.jpg
Global Drug Delivery Partnering Deals and Agreements Report & Directory 2014-2020
February 10, 2021 08:03 ET | Research and Markets
Dublin, Feb. 10, 2021 (GLOBE NEWSWIRE) -- The "Global Drug Delivery Partnering Terms and Agreements 2014-2020" report has been added to ResearchAndMarkets.com's offering. The Global Drug Delivery...
22157.jpg
Global Liposomal Drug Delivery Devices Market Report 2020: Market is Expected to Recover and Reach $4.43 Billion in 2023 at a CAGR of 10.27% - Forecast to 2030
February 02, 2021 06:28 ET | Research and Markets
Dublin, Feb. 02, 2021 (GLOBE NEWSWIRE) -- The "Liposomal Drug Delivery Devices Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering....
Geocann Logo_Full (002).png
Geocann and Pathway Health form a strategic partnership to supply VESIsorb® formulated medical cannabis products to leading retail pharmacy brands throughout Canada
January 27, 2021 09:45 ET | Geocann
FORT COLLINS, Colo., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Geocann is proud to announce a strategic partnership with Pathway Health Corp. (“PHC”) that will bring VESIsorb® formulated products to the...
22157.jpg
Global Cardiovascular Drug Delivery Report 2020: Technologies, Markets & Companies Analysis & Forecasts 2018-2028
January 07, 2021 09:33 ET | Research and Markets
Dublin, Jan. 07, 2021 (GLOBE NEWSWIRE) -- The "Cardiovascular Drug Delivery - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's...
22157.jpg
Global Central Nervous System Diseases Drug Delivery Markets, 2019-2020 & Projections to 2024 and 2029
September 17, 2020 04:13 ET | Research and Markets
Dublin, Sept. 17, 2020 (GLOBE NEWSWIRE) -- The "Drug Delivery in Central Nervous System Diseases - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to...
Geocann inks supply and distribution agreement with Opticann, a new U.S.-based company founded by former MedReleaf executives
August 06, 2020 16:00 ET | Geocann
FORT COLLINS, Colo., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Geocann is proud to announce a strategic partnership with Opticann Inc. (“Opticann”) that will bring VESIsorb® formulated hemp products into...
Second Shipment of Dried Cannabis Materials Shipped to Pharmacy Australia Centre of Excellence by PreveCeutical’s Canadian Licensed Producer Partner for Novel Nose-to-Brain Drug Delivery Research
May 03, 2018 09:30 ET | PreveCeutical Medical Inc.
VANCOUVER, British Columbia, May 03, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) (OTCQB:PRVCF) (FSE:18H), announces the grant...